Author:
Wang Rou,Tomlins Scott A.,Chinnaiyan Arul M.
Reference67 articles.
1. Afar, D.E., Vivanco, I., Hubert, R.S., et al. 2001. Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia. Cancer Research 61:1686–1692.
2. Attard, G., Belldegrun, A.S., and de Bono, J.S. 2005. Selective blockade of androgenic steroid synthesis by novel lyase inhibitors as a therapeutic strategy for treating metastatic prostate cancer. BJU International 96:1241–1246.
3. Barry, M., Perner, S., Demichelis, F., et al. 2007. TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications. Urology 70:630–633.
4. Cerveira, N., Ribeiro, F.R., Peixoto, A., et al. 2006. TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions. Neoplasia 8:826–832.
5. Chen, C.D., Welsbie, D.S., Tran, C., et al. 2004. Molecular determinants of resistance to antiandrogen therapy. Nature Medicine10:33–39.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Genomics of Prostate Cancer;Stem Cells and Human Diseases;2011-12-19